Retrospective Study on relationship between CD73 expression in biliary tract cancer and the underlying biological mechanisms

Retrospective Study on relationship between CD73 expression in biliary tract cancer and its progression and prognosis, and the underlying biological mechanisms - Study on relationship between CD73 expression in biliary tract cancer and the underlying biological mechanisms

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051855

Enrollment

650

Registered

2023-08-07

Start date

2023-06-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary tract cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed as pathologically (cytology/biospy/surgery) having biliary tract cancer 2) Patients giving informed consent to anticipating in this study by oneself/a legal representative

Exclusion criteria

Exclusion criteria: 1) Patients diagnosed as having another malignancy within the past 3 years 2) Patients not giving informed consent to anticipating in this study by oneself/a legal representative 3) Patients deemed inappropriate by the investigator

Design outcomes

Primary

Measure	Time frame
Relationship between CD73 expression in the biliary tract cancer specimen and overall survival of patients with biliary tract cancer	—

Countries

Japan

Contacts

Public ContactMasaki Kuwatani

Hokkaido University Hospital Gastroenterology and Hepatology

mkuwatan@med.hokudai.ac.jp011-716-1161

Outcome results